Impact of Malaria on Hematological Profiles, Iron Indices, and G6PD Activity in Pregnant Women
DOI:
https://doi.org/10.31964/mltj.v12i1.739Keywords:
Anemia, glucose-6-phosphate dehydrogenase activity, hematological profiles, iron indices malaria, serum ironAbstract
The global prevalence and impact of malaria on pregnancy highlight a significant public health challenge that demands enhanced preventive measures and targeted interventions. The study aimed to assess the hematological, iron, and G6PD status among pregnant women infected with Plasmodium falciparum. We performed a comparative cross-sectional study among two hundred (200) pregnant women infected with Plasmodium falciparum, who attended Edo Specialist Hospital, Benin City, to assess the hematological, iron, and G6PD status compared with fifty (50) Plasmodium falciparum-free pregnant women as controls. Hematological parameters, iron, TIBC (total iron binding capacity), and G6PD activity were assessed using a hematology auto analyzer and spectrophotometric methods, respectively. Data obtained were analyzed using SPSS (IBM v26). Independent t-test and one-way analysis of variance (ANOVA) were used for continuous variables, and chi-square was used for categorical variables. Pregnant women infected with Plasmodium falciparum had 8.70%, 9.42%, 14.44%, 8.1%, 20.17%, 16.72%, 11.31%, and 27.8% reduction in red blood cell, hemoglobin, iron, packed cell volume, G6PD, total iron binding capacity, monocyte, and lymphocyte levels, respectively, compared to Plasmodium falciparum-free pregnant women as controls (p<0.05). In addition, the levels of white blood cell, platelets, and neutrophils witness 15.58%, 10.85%, and 24.02% increase in pregnant women infected with Plasmodium falciparum compared with plasmodium falciparum free pregnant women as controls (p<0.05). No significant differences were observed in serum iron and G6PD levels across gestational ages (p>0.05). The findings underscore the need of regular monitoring of hematological and biochemical parameters in pregnant women infected with Plasmodium falciparum in order to enhance policy on malaria prevention and screening in endemic regions.References
Accrombessi, M., Gartner, A., Briand, V., Cottrell, G., Agbota, G., & Yovo, E. (2018). Effects of malaria in the first trimester of pregnancy on poor maternal and birth outcomes in Benin. Clinical Infectious Diseases, 69(8), 1385–1393.
Akbarpour, E., Mard, A., Abolnezhadian, F., Paridar, Y., Zamani, M., & Azadpour, S. (2022). Anemia prevalence, severity, types, and correlates among adult women and men in a multiethnic Iranian population: The Khuzestan Comprehensive Health Study (KCHS). BMC Public Health, 22(1). 12-17
Bakrim, S., Ouarour, A., Motiaa, Y., & Masrar, A. (2018). Hematological parameters of the blood count in a healthy population of pregnant women in the Northwest of Morocco (Tetouan-M’diq-Fnideq provinces). Pan African Medical Journal, 29.
Barakauskas, V. E., Dooley, K., Branch, E., Albert, A., Bohn, M. K., & Chan, W. S. (2023). Mining the gap: Deriving pregnancy reference intervals for hematology parameters using clinical datasets. Clinical Chemistry, 69(12), 1374–1384.
Basu, S., Anupurba, S., Verma, A., Kumar, A., & Kumar, D. (2018). Effect of maternal iron deficiency anemia on fetal neural development. Journal of Perinatology, 38(3), 233–239.
Bohn, M. K., & Adeli, K. (2022). Physiological and metabolic adaptations in pregnancy: Importance of trimester-specific reference intervals to investigate maternal health and complications. Critical Reviews in Clinical Laboratory Sciences, 59(2), 76–92.
Bothwell, T. H. (2000). Iron requirements in pregnancy and strategies to meet them. The American Journal of Clinical Nutrition, 72(1 Suppl), 257S–264S. https://doi.org/10.1093/ajcn/72.1.257S
Burtis, C. A., & Bruns, D. E. (2015). Tietz fundamentals of clinical chemistry and molecular diagnostics (7th ed.). Elsevier.
Chen, X. (2006). Association of elevated serum iron levels and the risk of gestational diabetes mellitus in pregnant women: The Camden Study. Diabetes Care, 29(5), 1077–1082.
Costantine, M. M. (2014). Physiologic and pharmacokinetic changes in pregnancy. Frontiers in Pharmacology, 5, 198. 20-34
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007). Epidemiology and burden of malaria in pregnancy. The Lancet Infectious Diseases, 7(2), 93–104. https://doi.org/10.1016/S1473-3099(07)70021-X
Domingo, G. J., Advani, N., Satyagraha, A. W., Sibley, C. H., Rowley, E., & Kalnoky, M. (2019). Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: Challenges and opportunities. International Health, 11(1), 7–14.
Drakesmith, H., & Prentice, A. (2012). Hepcidin and the iron-infection axis. Science, 338(6108), 768–772. https://doi.org/10.1126/science.1224577
Feleke, D. G., Alemu, Y., & Yemanebirhane, N. (2021). Performance of rapid diagnostic tests, microscopy, loop-mediated isothermal amplification (LAMP) and PCR for malaria diagnosis in Ethiopia: A systematic review and meta-analysis. Malaria Journal, 20(1).
Fisher, A. L., & Nemeth, E. (2017). Iron homeostasis during pregnancy. The American Journal of Clinical Nutrition, 106(Suppl. 6), 1567S–1574S. https://doi.org/10.3945/ajcn.117.155812
Georgieff, M. K. (2023). The importance of iron deficiency in pregnancy on fetal, neonatal, and infant neurodevelopmental outcomes. International Journal of Gynecology & Obstetrics, 162(S2), 83–88.
Goheen, M. M., Bah, A., Wegmüller, R., Darboe, B., Danso, E., Affara, M., Gardner, D. S., Patel, J. C., Prentice, A. M., & Cerami, C. (2017). Host iron status and susceptibility to Plasmodium falciparum infection in pregnancy. Scientific Reports, 7, 17674. https://doi.org/10.1038/s41598-017-16896-z
Guyatt, H. L., & Snow, R. W. (2001). The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. The American Journal of Tropical Medicine and Hygiene, 64(1–2 Suppl), 36–44.
Helegbe, G. K., Wemakor, A., Ameade, E. P. K., Zorn, B. G., Anaba, F., & Bautista, J. M. (2023). Co-occurrence of G6PD deficiency and SCT among pregnant women exposed to infectious diseases. Journal of Clinical Medicine, 12(15), 5085.
Jain, K., Gupta, P., Salam, N., Balodhi, A., & Deeba, F. (2022). Prevalence of pregnancy-associated malaria in India. Frontiers in Global Women's Health, 3. 12-18
Kindzelskii, A. L., Huang, J. B., Kim, Y. M., Fahmy, R. M., Chaiworapongsa, T., Romero, R., et al. (2002). Pregnancy alters glucose-6-phosphate dehydrogenase trafficking, cell metabolism, and oxidant release of maternal neutrophils. The Journal of Clinical Investigation, 110(12), 1801–1811.
Li, A., Yang, S., Zhang, J., & Qiao, R. (2017). Establishment of reference intervals for complete blood count parameters during normal pregnancy in Beijing. Journal of Clinical Laboratory Analysis, 31(6), e22150.
Magatti, M., Stefani, F. R., Papait, A., Cargnoni, A., Masserdotti, A., & Silini, A. R. (2019). Perinatal mesenchymal stromal cells and their possible contribution to fetal-maternal tolerance. Cells, 8(11), 1401.
Mahamar, A., Swihart, B., Diarra, B. S., Sidibe, Y., Barry, A., & Dicko, A. (2021). Malaria infection is common and associated with perinatal mortality and preterm delivery despite widespread use of chemoprevention in Mali: An observational study 2010 to 2014. Clinical Infectious Diseases, 73(8), 1355–1361.
Maurya, P. K., Kumar, P., & Chandra, P. (2016). Age-dependent detection of erythrocyte glucose-6-phosphate dehydrogenase and its correlation with oxidative stress. Archives of Physiology and Biochemistry, 122(2), 61–66.
McLimore, H. M., Fischer, B. A., Kling, P. J., Coe, C. L., Pham, D. Q. D., & Blohowiak, S. E. (2013). Impact of multiple prenatal risk factors on newborn iron status at delivery. Journal of Pediatric Hematology/Oncology, 35(6), 473–477.
McPherson, R. A., & Pincus, M. R. (2021). Henry's clinical diagnosis and management by laboratory methods (24th ed.). Elsevier.
Menendez, C., D'Alessandro, U., & ter Kuile, F. O. (2010). Reducing the burden of malaria in pregnancy by preventive strategies. The Lancet Infectious Diseases, 10(2), 118–128. https://doi.org/10.1016/S1473-3099(09)70325-0
Nicol, C. J., Wells, P. G., Zielenski, J., & Tsui, L. (2000). An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. The FASEB Journal, 14(1), 111–127.
Obeagu, E. I., & Obeagu, G. U. (2024). Maternal malaria and the risk of subsequent pregnancy complications. International Journal of Medical Sciences and Pharma Research, 10(2), 18–25.
Rogerson, S. J., & Unger, H. W. (2022). Pregnancy and malaria: The perfect storm. Current Opinion in Infectious Diseases, 35(5), 410–416.
Shah, S. S., Diakite, S. A. S., Traore, K., Wellems, T. E., Rockett, K. A., & Kwiatkowski, D. P. (2012). A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Scientific Reports, 2. 34-42
Spottiswoode, N., Duffy, P. E., & Drakesmith, H. (2014). Iron, anemia and hepcidin in malaria. Frontiers in Pharmacology, 5, 125. https://doi.org/10.3389/ fphar.2014.00125
Tuncalp, Ö., Rogers, L. M., Lawrie, T. A., Barreix, M., Peña-Rosas, J. P., & Bucagu, M. (2020). WHO recommendations on antenatal nutrition: An update on multiple micronutrient supplements. BMJ Global Health, 5(7), e003375.
Van Santen, S., Kroot, J. J. C., Wiegerinck, E. T., Swinkels, D. W., Zijderveld, G., & Spaanderman, M. E. A. (2013). The iron regulatory hormone hepcidin is decreased in pregnancy: A prospective longitudinal study. Clinical Chemistry and Laboratory Medicine, 51(7). 12-20
Wagbatsoma, V. A., & Omoike, B. I. (2008). Prevalence and prevention of malaria in pregnancy in Edo State, Nigeria. African Journal of Reproductive Health, 12(3), 49–58.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Fidelis Ohiremen Oyakhire, Patricia Ejenawome Dele-Ochie, Juliana Edusola Olaniyan, Valentine Ikalumhe, Babatunde Ishola Gabriel Adejumo, Samson Efenarhua, Osamwonyi Ernest Igbinovia, Emmanuel Onosetale Afeikhena, Adebukola Adisa Ekoh-Jolly

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.




